Odyssey Health, Inc.
Data quality: 83%
ODYY
OTC
Manufacturing
Measuring & Analyzing Instruments
$0.07
▲
$0.00
(3.17%)
Mkt Cap: 6.49 M
Price
$0.07
Mkt Cap
6.49 M
Day Range
$0.05 — $0.05
52-Week Range
$0.01 — $0.13
Volume
45
Open $0.05
50D / 200D Avg
$0.06
10.17% above
50D / 200D Avg
$0.05
29.74% above
Quick Summary
Key Takeaways
Negative free cash flow of -620,457.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-1.23
Valuation
PE (TTM)
-1.41
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.4 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -4.59 M |
| ROE | N/A | ROA | -1061.07% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -620,457.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.06 |
| Interest Coverage | -1.23 | Asset Turnover | N/A |
| Working Capital | -10.60 M | Tangible Book Value | -10.60 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.41 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9.56% | ||
| Market Cap | 6.49 M | Enterprise Value | 6.49 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.05 | Revenue / Share | N/A |
| FCF / Share | -0.01 | OCF / Share | -0.01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 13.52% |
| SBC-Adj. FCF | -692,725 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0.0 |
| Net Income | -1.74 M | -842,316.0 | -5.92 M | -8.44 M | -16.88 M |
| EPS (Diluted) | -0.02 | -0.01 | -0.07 | -0.09 | — |
| Gross Profit | — | — | — | — | 0.0 |
| Operating Income | -1.02 M | 14.26 M | -5.31 M | -8.11 M | -15.86 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 0.0 | — | — | — | 1.63 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | 1,538.0 | 3,416.0 | 2,374.0 | 5,552.0 |
| Interest Expense | 252,516.0 | 518,476.0 | 614,083.0 | 836,294.0 | 1.07 M |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 49,723.0 | 586,146.0 | 455,793.0 | 569,677.0 | 610,533.0 |
| Total Liabilities | — | — | — | — | 3.38 M |
| Shareholders' Equity | -6.95 M | -5.33 M | -6.16 M | -4.64 M | -2.77 M |
| Total Debt | — | — | — | — | 0.0 |
| Cash & Equivalents | — | — | 36,865.0 | 72,534.0 | 556,584.0 |
| Current Assets | 49,723.0 | 56,943.0 | 405,888.0 | 526,417.0 | 610,119.0 |
| Current Liabilities | 7.00 M | 5.92 M | 6.61 M | 5.21 M | 3.38 M |
{"event":"ticker_viewed","properties":{"ticker":"ODYY","listing_kind":"stock","pathname":"/stocks/odyy","exchange":"OTC","country":"US"}}